XML 82 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments in associates and joint ventures
12 Months Ended
Dec. 31, 2018
Investments in joint ventures and associates [abstract]  
Investments in associates and joint ventures

The section presents information on the Barclays Bank Group’s investments in subsidiaries, joint ventures and associates and its interests in structured entities. Detail is also given on securitisation transactions the Barclays Bank Group has entered into and arrangements that are held off-balance sheet.

20182017
AssociatesJoint venturesTotalAssociatesJoint venturesTotal
£m£m£m£m£m£m
Equity accounted481281762402316718
Held at fair value through profit or loss-509509-447447
Total4817901,2714027631,165

Summarised financial information for the Barclays Bank Group’s equity accounted associates and joint ventures is set out below. The amounts shown are the net income of the investees, not just the Barclays Bank Group’s share for the year ended 31 December 2018, with the exception of certain undertakings for which the amounts are based on accounts made up to dates not earlier than three months before the balance sheet date.

AssociatesJoint ventures
2018201720182017
£m£m£m£m
Profit from continuing operations1731175477
Other comprehensive income / (expenses)28-32(15)
Total comprehensive income from continuing operations2011178662

Unrecognised shares of the losses of individually immaterial associates and joint ventures were £nil (2017: £nil).

The Barclays Bank Group’s associates and joint ventures are subject to statutory or contractual requirements such that they cannot make remittances of dividends or make loan repayments to Barclays Bank PLC without agreement from the external parties.

The Barclays Bank Group’s share of commitments and contingencies of its associates and joint ventures comprised unutilised credit facilities provided to customers of £1,715m (2017: £1,712m). In addition, the Barclays Bank Group has made commitments to finance or otherwise provide resources to its joint ventures and associates of £318m (2017: £246m).